GSK, Wavre, Belgium.
Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2031776. doi: 10.1080/21645515.2022.2031776. Epub 2022 Feb 18.
Developing and implementing new immunization policies in response to shifting epidemiology is a critical public health component. We adopted a mixed-methods approach (via narrative literature review [101 articles] and 9 semi-structured interviews) to evaluate policy development in response to shifting measles epidemiology in six European countries (Italy, Belgium, Germany, Romania, UK, and Ukraine); where policies and strategies have evolved in response to country-specific disease and vaccination patterns. Periodic outbreaks have occurred in all countries against a background of declining measles-containing-vaccine (MCV) uptake and increasing public vaccine hesitancy (with substantial regional or social differences in measles burden and vaccine uptake). Health-care worker (HCW) vaccine skepticism is also seen. While many outbreaks arise or involve specific susceptible populations (e.g., minority/migrant communities), the broader pattern is spread to the wider (and generally older) population; often among incompletely/non-vaccinated individuals as a legacy of previous low uptake. Immunization policy and strategic responses are influenced by political and social factors, where public mistrust contributes to vaccine hesitancy. A strong centralized immunization framework (allied with effective regional implementation and coherent political commitment) can effectively increase uptake. Mandatory vaccination has increased childhood MCV uptake in Italy, and similar benefits could be anticipated for other countries considering vaccine mandates. Although possible elsewhere, socio-political considerations render mandating impractical in other countries, where targeted immunization activities to bolster routine uptake are more important. Addressing HCW skepticism, knowledge gaps, improving access and increasing public/community engagement and education to address vaccine hesitancy/mistrust (especially in communities with specific unmet needs) is critical.
制定和实施新的免疫政策以应对不断变化的流行病学是公共卫生的一个关键组成部分。我们采用了混合方法(通过叙述性文献综述[101 篇文章]和 9 次半结构化访谈)来评估六个欧洲国家(意大利、比利时、德国、罗马尼亚、英国和乌克兰)应对麻疹流行病学变化的政策制定情况;这些国家的政策和战略是针对特定国家的疾病和疫苗接种模式而演变的。在麻疹疫苗接种率下降和公众对疫苗的犹豫情绪不断增加的背景下(麻疹负担和疫苗接种率在地区或社会上存在显著差异),所有国家都发生了周期性暴发。卫生保健工作者(HCW)对疫苗的怀疑也存在。虽然许多暴发涉及或涉及特定的易感人群(例如少数民族/移民社区),但更广泛的模式是传播到更广泛(通常是年龄较大)的人群;通常是在以前接种率较低的不完全/未接种人群中。免疫政策和战略反应受到政治和社会因素的影响,公众的不信任导致疫苗犹豫。强大的集中免疫框架(与有效的区域实施和一致的政治承诺相结合)可以有效地提高接种率。强制性疫苗接种提高了意大利儿童的麻疹疫苗接种率,其他考虑实施疫苗接种的国家也有望获得类似的益处。尽管在其他地方可能存在,但社会政治因素使得在其他国家实施强制性疫苗接种不切实际,在这些国家,更重要的是针对常规接种率提高的有针对性的免疫活动。解决卫生保健工作者的怀疑、知识差距、改善获取途径以及增加公众/社区的参与和教育以解决疫苗犹豫/不信任(特别是在有特定未满足需求的社区)是至关重要的。